| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |